Two HCC models’ different expression of FGF19 and FGFRs were used to determine the expression levels of regulators of angiogenesis such as PDGF-AA, CYR61, VEGF, TGF- β1, FGFs, and HGF [26] following treatments. This evidence concerns the gene FGF19 and hepatocellular carcinoma.